Peter Teriete
Company: IDEAYA Biosciences
Job title: Co-Founder
Seminars:
Panel Discussion: Unleashing the Power of CTCs to Revolutionize Biomarker Discovery & Transform Prognostic Insights 12:10 pm
How are CTC’s currently being utilized to shape precision medicine approaches? Exploring the power of exosomes in early cancer diagnostics to improve accuracy in tumour representation Leveraging alternative biological fluids to enhance the detection of better biomarkersRead more
day: Day Two Track A (AM)
Uncovering the Role of Circulating Cancer Cell Clusters in Metastasis & Therapeutic Targeting: A Novel Approach in Liquid Biopsy 5:00 pm
Circulating metastatic cancer cell clusters (MCCs) provide one of the worst prognoses for cancer patients Routine and efficient capture of MCCs is essential for diagnostic, prognostic, and therapeutic approaches Anti-metastatic drugs targeting MCCs independent of treatment against primary tumours are going to bring significant benefit to survival and quality of life to nearly all cancer…Read more
day: Day One Track A (2)